Jan de Groot

882 total citations
23 papers, 705 citations indexed

About

Jan de Groot is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jan de Groot has authored 23 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Jan de Groot's work include Immunotherapy and Immune Responses (7 papers), DNA Repair Mechanisms (6 papers) and T-cell and B-cell Immunology (5 papers). Jan de Groot is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), DNA Repair Mechanisms (6 papers) and T-cell and B-cell Immunology (5 papers). Jan de Groot collaborates with scholars based in Netherlands, United States and Germany. Jan de Groot's co-authors include Rik J. Scheper, Hans Joenje, Johan P. de Winter, Quinten Waisfisz, Maureen E. Hoatlin, Yu Zhi, Laura van der Weel, Fré Arwert, Martin A. Rooimans and Lucine Bosnoyan-Collins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Blood.

In The Last Decade

Jan de Groot

22 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan de Groot Netherlands 13 560 163 112 99 93 23 705
Nicki Gray United Kingdom 11 533 1.0× 123 0.8× 66 0.6× 46 0.5× 74 0.8× 12 704
Tadahiro Shiomi Japan 22 910 1.6× 287 1.8× 146 1.3× 167 1.7× 38 0.4× 46 997
R. Elli Italy 13 429 0.8× 97 0.6× 70 0.6× 97 1.0× 40 0.4× 33 581
Jiang-Cheng Shen United States 8 798 1.4× 370 2.3× 133 1.2× 133 1.3× 19 0.2× 8 1.0k
Lior Golomb Israel 11 726 1.3× 89 0.5× 52 0.5× 242 2.4× 89 1.0× 14 924
Nobuko Matsushita Japan 11 719 1.3× 293 1.8× 100 0.9× 124 1.3× 41 0.4× 17 811
Shoshana Squires United Kingdom 15 976 1.7× 280 1.7× 92 0.8× 293 3.0× 23 0.2× 18 1.1k
Godelieve Smeenk Netherlands 9 857 1.5× 75 0.5× 88 0.8× 285 2.9× 48 0.5× 11 920
John M. Hinz United States 21 1.1k 1.9× 312 1.9× 98 0.9× 198 2.0× 16 0.2× 30 1.2k
Guangzhen Hu United States 10 339 0.6× 162 1.0× 35 0.3× 107 1.1× 100 1.1× 13 575

Countries citing papers authored by Jan de Groot

Since Specialization
Citations

This map shows the geographic impact of Jan de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan de Groot more than expected).

Fields of papers citing papers by Jan de Groot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan de Groot. The network helps show where Jan de Groot may publish in the future.

Co-authorship network of co-authors of Jan de Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Jan de Groot. A scholar is included among the top collaborators of Jan de Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan de Groot. Jan de Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hangalapura, Basav N., Dinja Oosterhoff, Jan de Groot, et al.. (2011). Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine. Cancer Research. 71(17). 5827–5837. 26 indexed citations
2.
Hangalapura, Basav N., Dinja Oosterhoff, Tarun Gupta, et al.. (2011). Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine. Vaccine. 29(12). 2313–2321. 18 indexed citations
3.
Bontkes, Hetty J., Marı́a Moreno, Basav N. Hangalapura, et al.. (2010). Attenuation of invariant Natural Killer T-cell anergy induction through intradermal delivery of α-galactosylceramide. Clinical Immunology. 136(3). 364–374. 22 indexed citations
4.
Ven, Rieneke van de, Jan de Groot, Anneke W. Reurs, et al.. (2009). Unimpaired immune functions in the absence of Mrp4 (Abcc4). Immunology Letters. 124(2). 81–87. 10 indexed citations
5.
Lelij, Petra van der, Barbara C. Godthelp, Wouter van Zon, et al.. (2009). The Cellular Phenotype of Roberts Syndrome Fibroblasts as Revealed by Ectopic Expression of ESCO2. PLoS ONE. 4(9). e6936–e6936. 59 indexed citations
6.
Molling, Johan W., Marı́a Moreno, Jan de Groot, et al.. (2008). Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases. Immunology Letters. 118(1). 36–43. 9 indexed citations
7.
Groot, Jan de, et al.. (2006). An Introduction to Managing Medullary Thyroid Cancer. Hereditary Cancer in Clinical Practice. 4(3). 115–115. 3 indexed citations
8.
Medhurst, Annette L., El Houari Laghmani, Jûrgen Steltenpool, et al.. (2006). Evidence for subcomplexes in the Fanconi anemia pathway. Blood. 108(6). 2072–2080. 75 indexed citations
9.
Mossink, Marieke H., Jan de Groot, Arend van Zon, et al.. (2003). Unimpaired dendritic cell functions in MVP/LRP knockout mice. Immunology. 110(1). 58–65. 21 indexed citations
10.
Vrugt, Henri J. van de, Yne de Vries, Martin A. Rooimans, et al.. (2002). Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg. Genes to Cells. 7(3). 333–342. 16 indexed citations
11.
Rustemeyer, Thomas, Jan de Groot, B. Mary E. von Blomberg, et al.. (2002). Assessment of contact allergen cross‐reactivity by retesting. Experimental Dermatology. 11(3). 257–265. 12 indexed citations
12.
Vrugt, Henri J. van de, Ngan Ching Cheng, Yne de Vries, et al.. (2000). Cloning and characterization of murine Fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary. Mammalian Genome. 11(4). 326–331. 29 indexed citations
13.
Winter, Johan P. de, Martin A. Rooimans, Laura van der Weel, et al.. (2000). The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nature Genetics. 24(1). 15–16. 218 indexed citations
14.
Waisfisz, Quinten, Johan P. de Winter, Frank A.E. Kruyt, et al.. (1999). A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proceedings of the National Academy of Sciences. 96(18). 10320–10325. 133 indexed citations
15.
Scheper, Rik J., et al.. (1996). Reversal of Orally Induced T‐Cell Tolerance by Subcutaneous Administration of Interleukin‐12 at the Site of Attempted Sensitization. Annals of the New York Academy of Sciences. 795(1). 403–409. 1 indexed citations
16.
Groot, Jan de, et al.. (1993). Peripolesis in Alveolar Sarcoidosis. American Review of Respiratory Disease. 147(5). 1259–1263. 8 indexed citations
17.
Groot, Jan de, et al.. (1992). Development of a Concomitant Nickel and Chromium Sensitization Model in the Guinea Pig. International Archives of Allergy and Immunology. 97(4). 258–266. 22 indexed citations
18.
Groot, Jan de, et al.. (1991). Proliferative capacity of mononuclear cells in the human lung. Journal of Immunological Methods. 143(1). 95–102. 2 indexed citations
19.
Mullink, H., et al.. (1991). Macrophage-T Suppressor Cell Interference in the Lungs of Steroid-treated Sarcoidosis Patients. American Review of Respiratory Disease. 143(4_pt_1). 839–843. 3 indexed citations
20.
Groot, Jan de. (1968). La Iglesia como sacramento del mundo. Concilium: Revista internacional de teología. 58–74.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026